Enzolytics Inc (ENZC)

[suny66]

Keep your ear to the ground for Roche(Europe) and its fully owned subsidiary Genentech. GILD developed Tamiflu and licensed it to Roche some years ago. The Tamiflu patent has been expired for some time and the generic Oseltamivir form of Tamiflu is available with a script. So, Roche is not generating the nice profits from Tamiflu anymore. An interesting observation is that John Rim-, CEO of Samsung worked in upper management for both Roche and Genentech for many years before going with Samsung. It is expected that ITV-1 will be seeking EMA approval. With Rim's knowledge of Tamiflu and prior association with Roche and Genentech, might there be the possibility of some kind of deal involving IPF and or ITV-1? Is that why IPF was halted in the US and the NDA was extended?? This is my one message that I am allowed today.